Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Evaluation of the Effect of the Erchonia ALS on Alzheimer's Disease

NCT02537626 is registered in ClinicalTrials.gov with Erchonia Corporation as lead sponsor.

NCT NCT02537626
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02537626 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Evaluation of the Effect of the Erchonia ALS on Alzheimer's Disease
Lead sponsor
Erchonia Corporation
Phase
Not applicable
Overall status
Completed
Start date
March 15, 2018
Completion date
October 15, 2020
Enrollment
43 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease